Jan Willem Kleinovink

4PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 21, 2021
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.

Elham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas

|Oct 01, 2020
Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models.

Marit van Elsas, Jan Willem Kleinovink, Matthijs Moerland

|Sep 03, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.

Elham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman

|Mar 11, 2018
A Restricted Role for FcγR in the Regulation of Adaptive Immunity.

Marieke F Fransen, Hreinn Benonisson, Wendy W van Maren

Pageof 1